| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.37B | — | +14.9% |
| Cost of Revenue | $586.0M | — | +15.1% |
| Gross Profit | $785.0M | — | +14.8% |
| R&D Expense | $97.0M | — | +3.2% |
| SG&A Expense | $381.0M | — | +11.7% |
| Pre-tax Income | $87.0M | — | +45.0% |
| Income Tax | $30.0M | — | +528.6% |
| Net Income | $57.0M | — | -14.9% |
| EPS (Basic) | $0.11 | — | -21.4% |
| EPS (Diluted) | $0.11 | — | -15.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $428.0M | -21.5% | -12.1% |
| Accounts Receivable | $1.08B | +24.2% | +11.8% |
| Inventory | $1.72B | -1.2% | +7.9% |
| Current Assets | $3.58B | +3.6% | +4.2% |
| Total Assets | $13.22B | -1.0% | +2.2% |
| Current Liabilities | $1.66B | +4.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $13.0M | — | +425.0% |
| Capital Expenditures | $51.0M | — | -21.5% |
| Investing Cash Flow | -$60.0M | — | -3.4% |
| Financing Cash Flow | -$65.0M | — | -225.0% |
| Free Cash Flow | -$38.0M | — | +44.9% |
| +31.0% |
| Long-term Debt | $3.74B | -0.7% | -15.0% |
| Total Liabilities | $6.72B | -1.3% | +2.0% |
| Stockholders' Equity | $6.50B | -0.7% | +2.3% |